Thomas Hankemeier
Thomas Hankemeier
Professor of Analytical Biosciences, Leiden University
Verified email at - Homepage
Cited by
Cited by
Proposed minimum reporting standards for chemical analysis: chemical analysis working group (CAWG) metabolomics standards initiative (MSI)
LW Sumner, A Amberg, D Barrett, MH Beale, R Beger, CA Daykin, ...
Metabolomics 3, 211-221, 2007
Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research
A Scalbert, L Brennan, O Fiehn, T Hankemeier, BS Kristal, B van Ommen, ...
Metabolomics 5, 435-458, 2009
Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics
WB Dunn, A Erban, RJM Weber, DJ Creek, M Brown, R Breitling, ...
Metabolomics 9, 44-66, 2013
Microfluidic 3D cell culture: from tools to tissue models
V Van Duinen, SJ Trietsch, J Joore, P Vulto, T Hankemeier
Current opinion in biotechnology 35, 118-126, 2015
Metabolomics enables precision medicine:“a white paper, community perspective”
RD Beger, W Dunn, MA Schmidt, SS Gross, JA Kirwan, M Cascante, ...
Metabolomics 12, 1-15, 2016
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients [S]
M Janssens, J van Smeden, GS Gooris, W Bras, G Portale, PJ Caspers, ...
Journal of lipid research 53 (12), 2755-2766, 2012
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—an emerging role for gut microbiome
S MahmoudianDehkordi, M Arnold, K Nho, S Ahmad, W Jia, G Xie, ...
Alzheimer's & Dementia 15 (1), 76-92, 2019
Microbial metabolomics with gas chromatography/mass spectrometry
MM Koek, B Muilwijk, MJ van der Werf, T Hankemeier
Analytical chemistry 78 (4), 1272-1281, 2006
Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectives
MM Koek, RH Jellema, J van der Greef, AC Tas, T Hankemeier
Metabolomics 7, 307-328, 2011
Metabolic network failures in Alzheimer's disease: A biochemical road map
JB Toledo, M Arnold, G Kastenmüller, R Chang, RA Baillie, X Han, ...
Alzheimer's & Dementia 13 (9), 965-984, 2017
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474
ACM van Esbroeck, APA Janssen, AB Cognetta III, D Ogasawara, ...
Science 356 (6342), 1084-1087, 2017
LC/MS analysis of stratum corneum lipids: ceramide profiling and discovery [S]
J van Smeden, L Hoppel, R van der Heijden, T Hankemeier, RJ Vreeken, ...
Journal of lipid research 52 (6), 1211-1221, 2011
Simultaneous quantitative analysis of metabolites using ion-pair liquid chromatography− electrospray ionization mass spectrometry
L Coulier, R Bas, S Jespersen, E Verheij, MJ van der Werf, T Hankemeier
Analytical chemistry 78 (18), 6573-6582, 2006
Analytical strategies in lipidomics and applications in disease biomarker discovery
C Hu, R van der Heijden, M Wang, J van der Greef, T Hankemeier, G Xu
Journal of Chromatography B 877 (26), 2836-2846, 2009
Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes
SJ Trietsch, E Naumovska, D Kurek, MC Setyawati, MK Vormann, ...
Nature communications 8 (1), 262, 2017
Comprehensive LC−MSE Lipidomic Analysis using a Shotgun Approach and Its Application to Biomarker Detection and Identification in Osteoarthritis Patients
JM Castro-Perez, J Kamphorst, J DeGroot, F Lafeber, J Goshawk, K Yu, ...
Journal of proteome research 9 (5), 2377-2389, 2010
Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery
K Strassburg, AML Huijbrechts, KA Kortekaas, JH Lindeman, ...
Analytical and bioanalytical chemistry 404, 1413-1426, 2012
Microbial metabolomics: toward a platform with full metabolome coverage
MJ van der Werf, KM Overkamp, B Muilwijk, L Coulier, T Hankemeier
Analytical biochemistry 370 (1), 17-25, 2007
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: relationship to neuroimaging and CSF biomarkers
K Nho, A Kueider-Paisley, S MahmoudianDehkordi, M Arnold, ...
Alzheimer's & Dementia 15 (2), 232-244, 2019
Metabolomics-based systems biology and personalized medicine: moving towards n= 1 clinical trials?
J Van Der Greef, T Hankemeier, RN McBurney
Future Medicine Ltd 7 (7), 1087-1094, 2006
The system can't perform the operation now. Try again later.
Articles 1–20